Micro-MRI at 11.7 T of a Murine Brain Tumor Model Using Delayed Contrast Enhancement

被引：13

作者：

Moats, Rex A. ^{[1
,2
,3
]}

Velan-Mullan, Sendhil ^{[2
]}

Jacobs, Russell ^{[2
]}

Gonzalez-Gomez, Ignacio ^{[1
]}

Dubowitz, David J. ^{[1
]}

Taga, Takashi ^{[1
]}

Khankaldyyan, Vazgen ^{[1
]}

Schultz, Linda ^{[1
]}

Fraser, Scott ^{[2
]}

Nelson, Marvin D. ^{[1
]}

Laug, Walter E. ^{[1
]}

机构：

[1] USC Keck School of Medicine, Los Angeles, CA

[2] California Institute of Technology, Pasadena, CA

[3] Department of Radiology, Childrens Hospital Los Angeles, MS 81, Los Angeles, CA 90027

来源：

Molecular Imaging | 2003年 / 2卷 / 03期

关键词：

Magnetic resonance imaging - Medical imaging - Pathology - Tumors;

D O I：

10.1162/153535003322556895

中图分类号：

学科分类号：

摘要：

In vivo imaging methodologies allow for serial measurement of tumor size, circumventing the need for sacrificing mice at given time points. In orthotopically transplanted murine models of brain tumors, cross-section micro-MRI allows for visualization and measurement of the physically inaccessible tumors. To allow for long resident times of a contrast agent in the tumor, intraperitoneal administration was used as a route of injection for contrast-enhanced micro-MRI, and a simple method for relative tumor volume measurements was examined. A strategy for visualizing the variability of the delayed tumor enhancement was developed. These strategies were applied to monitor the growth of brain tumors xenotransplanted into nude mice and either treated with the antiangiogenic peptide EMD 121974 or an inactive control peptide. Each mouse was used as its own control. Serial imaging was done weekly, beginning at Day 7 after tumor cell implantation and continued for 7 weeks. Images obtained were reconstructed on the MKI instrument. The image files were transferred off line to be postprocessed to assess tumor growth (volume) and variability in enhancement (three-dimensional [3-D] intensity models). In a small study, tumor growth and response to treatment were followed using this methodology and the high-resolution images displayed in 3-D allowed for straightforward qualitative assessment of variable enhancement related to vascular factors and tumor age.

引用

页码：150 / 158

页数：8

共 33 条

[1]

Fidler I.J., Yano S., Zhang R.D., Fujimaki T., Bucana C.D., The seed and soil hypothesis: Vascularisation and brain metastases, Lancet Oncol, 3, pp. 53-57, (2002)

[2]

Fidler I.J., Angiogenic heterogeneity: Regulation of neoplastic angiogenesis by the organ microenvironment, J Natl Cancer Inst, 93, pp. 1040-1041, (2001)

[3]

Killion J.J., Radinsky R., Fidler I.J., Orthotopic models are necessary to predict therapy of transplantable tumors in mice, Cancer Metastasis Rev, 17, pp. 279-284, (1998)

[4]

Gohji K., Nakajima M., Boyd D., Dinney C.P., Bucana C.D., Kitazana S., Kamidono S., Fidler I.J., Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells, Am J Pathol, 151, pp. 1655-1661, (1997)

[5]

Gutman M., Singh R.K., Xie K., Bucana C.D., Fidler I.J., Regulation of interleukin-8 expression in human melanoma cells by the organ environment, Cancer Res, 55, pp. 2470-2475, (1995)

[6]

Singh R.K., Bucana C.D., Gutman M., Fan D., Wilson M.R., Fidler U., Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells, Am J Pathol, 145, pp. 365-374, (1994)

[7]

Price J., Naito S., Fidler I.J., Growth in an organ micro-environment as a selective process in metastasis, Clin Exp Metastasis, 7, pp. 91-102, (1988)

[8]

Radinsky R., Fidler I.J., Regulation of tumor cell growth at organ-specific metastases, In Vivo, 6, pp. 325-331, (1992)

[9]

Fidler I.J., Wilmanns C., Staroselsky A., Radinsky R., Dong, Fan D., Modulation of tumor cell response to chemotherapy by the organ environment, Cancer Metastasis Rev, 13, pp. 209-222, (1994)

[10]

Taga T., Suzuki A., Gonzalez-Gomez I., Gilles F.H., Stins M., Shimada H., Barsky L., Weinberg K.I., Laug W.E., Alpha v-integrin antagonist HMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin, Int J Cancer, 98, pp. 690-697, (2002)

← 1 2 3 4 →